DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

AZD-7762

Generic Name: AZD-7762

Drug Type: Small Molecule

Chemical Formula: C_₁₇H_₁₉FN_₄O_₂S

CAS Number: 860352-01-8

Unique Ingredient Identifier: 5D822Y3L1H

Overview

AZD7762 has been investigated for the treatment of Cancer, Solid Tumors, and Advanced Solid Malignancies.

Background

AZD7762 has been investigated for the treatment of Cancer, Solid Tumors, and Advanced Solid Malignancies.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine

Phase 1

Terminated

Posted: 2009/07/13

Sponsor:AstraZeneca

Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan

Phase 1

Terminated

Posted: 2007/05/15

Sponsor:AstraZeneca

Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid Malignancies

Phase 1

Completed

Posted: 2006/12/20

Sponsor:AstraZeneca

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy